| Bioactivity | Nastorazepide (Z-360) hemicalcium, selective, orally available, 1,5-benzodiazepine derivative, is a gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antitumor activity[1]. |
| CAS | 343326-69-2 |
| Formula | C29H36N4O5.1/2Ca |
| Molar Mass | 540.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kato H, et al. CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. Life Sci. 2011 Oct 24;89(17-18):603-8. |
Nastorazepide hemicalcium
CAS: 343326-69-2 F: C29H36N4O5.1/2Ca W: 540.66
Nastorazepide (Z-360) hemicalcium, selective, orally available, 1,5-benzodiazepine derivative, is agastrin/cholecystokin
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.